Development and Characterization of a New Antipeptide Monoclonal Antibody Directed to Human CD20 Antigen-Reference-Cited by-同舟云学术

Development and Characterization of a New Antipeptide Monoclonal Antibody Directed to Human CD20 Antigen

Published:2015-09 Issue:7 Volume:30 Page:310-316
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Habibi-Anbouhi Mahdi¹,Azadmanesh Kayhan²,Behdani Mahdi³,Hajizadeh-Saffar Ensiyeh⁴,Vahabpour Rouhollah⁵,Shokrgozar Mohammad Ali¹

Affiliation:

1. National Cell Bank of Iran, Pasteur Institute of Iran. Tehran, Iran.

2. Department of Virology, Pasteur Institute of Iran, Tehran, Iran.

3. Venom & Biotherapeutics Molecules Laboratory, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

4. Department of Regenerative Medicine at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

5. Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2015.1863

Reference36 articles.

1. Preparation of antibody against horseradish peroxidase using hybridoma technology

2. A High-Throughput Hybridoma Selection Method Using Fluorometric Microvolume Assay Technology

3. A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies

4. Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneous surface-modified nanoplatforms for the targeted therapy of haematological malignancies;Drug Discovery Today;2020-01

2. Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia;Human Antibodies;2018-02-18

3. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells;Journal of Experimental & Clinical Cancer Research;2017-02-06